<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management of osteochondritis dissecans (OCD)</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management of osteochondritis dissecans (OCD)</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Management of osteochondritis dissecans (OCD)</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Albert C Hergenroeder, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Brian S Harvey, DO</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathy Boutis, MD, FRCPC, FAAP, MSc</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan Grayzel, MD, FAAEM</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 12, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H313966"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>OCD refers to osteonecrosis of subchondral bone and most often occurs in the knee, elbow, or ankle of school-age and adolescent children where it causes pain. Plain radiographs are frequently diagnostic. Sports medicine and orthopedic specialists usually determine the staging and stability of OCD lesions by magnetic resonance imaging. Initial treatment of stable lesions typically consists of rest, nonsteroidal antiinflammatory drugs, avoidance of high intensity activities, and physical therapy. Patients who are skeletally immature frequently do well with nonoperative therapy. Patients who have large lesions or develop intraarticular loose bodies usually need surgery.</p><p>This topic will discuss the management of OCD. The clinical manifestations and diagnosis of OCD and other causes of knee, elbow, or ankle pain in the young athlete are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/17003.html" rel="external">"Osteochondritis dissecans (OCD): Clinical manifestations, evaluation, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6514.html" rel="external">"Approach to acute knee pain and injury in children and skeletally immature adolescents"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6515.html" rel="external">"Approach to chronic knee pain or injury in children or skeletally immature adolescents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6524.html" rel="external">"Elbow injuries in active children or skeletally immature adolescents: Approach"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6530.html" rel="external">"Ankle pain in the active child or skeletally immature adolescent: Overview of causes"</a>.)</p><p></p><p class="headingAnchor" id="H6044707"><span class="h1">INDICATIONS FOR SUBSPECIALTY REFERRAL OR CONSULTATION</span><span class="headingEndMark"> — </span>The need for sports medicine or orthopedic specialty referral primarily depends upon the likelihood that the OCD lesion will not heal with nonoperative therapy. Healing is largely determined by skeletal maturity, characteristics of the OCD lesion (ie, size or stability), and the joint affected [<a href="#rid1">1</a>].</p><p>The following patients with OCD warrant referral to a sports medicine or orthopedic specialist:</p><p class="bulletIndent1"><span class="glyph">●</span>Skeletally immature patients (ie, open growth plates) with unstable (ie, partially or completely detached) OCD lesions of the knee or elbow (Stage II, III, or IV,  (<a class="graphic graphic_table graphicRef85755" href="/z/d/graphic/85755.html" rel="external">table 1</a>)) based upon on plain radiographs, magnetic resonance imaging (MRI), or both.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Skeletally immature patients with large, stable (Stage 1) lesions (parameters for the knee include &gt;2 cm in length, &gt;6 percent scaled surface area on MRI, or &gt;200 mm<sup>2</sup> surface area on MRI; for the elbow lesions affecting &gt;50 percent of the capitellum surface) [<a href="#rid1">1-4</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Skeletally immature patients with clinical findings of a loose body in the joint (eg, locking or catching).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Skeletally mature patients (ie, closed growth plates) regardless of affected joint, lesion size, or stage.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who have persistent or worsening signs and symptoms despite nonoperative management.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>All patients with OCD of the joints other than the knee or elbow.</p><p></p><p>Skeletally immature children with stable lesions that are small (parameters for the knee are &lt;2 cm in length, &lt;6 percent scaled surface area or &lt;200 mm<sup>2</sup> on MRI; for the elbow lesions affecting &lt;50 percent of the capitellum surface) and located in the knee or elbow often do well with nonoperative therapy alone and can frequently be treated by a knowledgeable primary care provider who is comfortable with overseeing the selected form of immobilization (casting, splinting, or brace) and ordering the necessary follow-up imaging to determine healing.</p><p class="headingAnchor" id="H315746"><span class="h1">NONOPERATIVE TREATMENT</span><span class="headingEndMark"> — </span>The nonoperative management of OCD is based upon case series and expert opinion and consists of restriction of activities, immobilization, and physical therapy [<a href="#rid3">3</a>]. We suggest that children with Stage I, II, or III juvenile OCD of the knee, elbow, or ankle  (<a class="graphic graphic_table graphicRef85755" href="/z/d/graphic/85755.html" rel="external">table 1</a>) initially undergo nonoperative therapy rather than surgical repair [<a href="#rid1">1,3</a>]. Skeletally immature patients with an intraarticular loose body (Stage IV lesion) warrant timely surgery to prevent permanent joint damage. (See <a class="local">'Surgical treatment'</a> below.)</p><p>Depending upon the disease stage, healing rates with nonoperative management of juvenile OCD vary from approximately 50 to more than 90 percent for lesions in the knee or elbow [<a href="#rid4">4-6</a>] and approximately 45 to 65 percent for the talus (ankle) [<a href="#rid7">7-9</a>] with the highest healing rates occurring in patients with Stage I OCD [<a href="#rid2">2,3,10,11</a>].</p><p>Nonoperative treatment is a reasonable first option for patients with adult OCD who have small, stable (Stage I or II) lesions  (<a class="graphic graphic_table graphicRef85755" href="/z/d/graphic/85755.html" rel="external">table 1</a>) although the likelihood of healing is approximately 50 percent or less.</p><p>Resolution of pain and documented healing of the subchondral bone guide the duration of nonoperative treatment and determine when the athlete can resume activities.</p><p class="headingAnchor" id="H9419138"><span class="h2">Restriction of activities</span><span class="headingEndMark"> — </span>Limitation of activity during nonoperative treatment is of critical importance. Once diagnosed, the athlete should be removed from sports and should not return until resolution of symptoms and evidence of healing on imaging has occurred. Rest is initially enforced through immobilization for four to six weeks. The duration of immobilization depends upon clinical response. (See <a class="local">'Immobilization'</a> below.)</p><p>For OCD of the knee or ankle, once immobilization has occurred and healing is evident, the patient should begin ambulation and receive physical therapy (PT) designed to increase strength and mobility at the joint. Swimming and cycling are additional activities that can help build strength and mobility while putting less impact on the knee or ankle. Slow return to sports may begin once the patient is asymptomatic, has completed PT, and has no pain with running, sprinting or cutting (sudden change in direction while running), which typically takes six months [<a href="#rid12">12</a>]. (See <a class="local">'Physical therapy'</a> below.)</p><p>Rest for OCD of the elbow includes no throwing, repetitive overhead movements, or elbow impact sports (eg, gymnastics) along with immobilization and PT [<a href="#rid4">4</a>]. Timing for return to play depends upon the response of the lesion to nonoperative therapy and, as for OCD of the knee or ankle, typically occurs at six months.</p><p class="headingAnchor" id="H315754"><span class="h2">Immobilization</span><span class="headingEndMark"> — </span>Children with juvenile OCD who are undergoing nonoperative treatment typically receive immobilization by cast, splint or knee immobilizer, hinged brace (knee or elbow), or a controlled ankle motion (CAM) walker boot until pain and radiographic evidence of healing is present. Casting may be preferred when adherence to immobilization in a very active athlete is <strong>not</strong> assured. The typical duration of initial immobilization is four to six weeks. If symptoms are not resolved or radiographic healing is not evident by six weeks, some experts suggest one week of cast or splint removal with physical therapy to decrease the potential for contractions and atrophy followed by a second four to six week period of casting or splinting.</p><p>Initial immobilization varies based upon the joint involved:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Knee</strong> – Hinged knee brace, nonweightbearing cast or long leg knee immobilizer with partial weight bearing with crutch assistance</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Elbow</strong> – Long arm cast or splint; a hinged elbow brace locked into slight flexion could also be used</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ankle</strong> – Stage I lesions  (<a class="graphic graphic_table graphicRef85755" href="/z/d/graphic/85755.html" rel="external">table 1</a>): splint or brace, stage II and III lesions: cast (preferred for stage III lesions) or below the knee controlled ankle motion (CAM) walker boot</p><p></p><p>Once initial immobilization has resulted in healing, we continue bracing during recovery and physical therapy.</p><p class="headingAnchor" id="H315762"><span class="h2">Physical therapy</span><span class="headingEndMark"> — </span>Physical therapy (PT) improves strength, mobility, and flexibility of the affected joint and is also important to counteract atrophy and contractions associated with immobilization [<a href="#rid10">10-12</a>]. PT should improve both active and passive range of motion of the affected joint and should commence once the patient has resolution of pain and evidence of bony healing on imaging.</p><p>PT should be continued until the patient is pain free, has full range of motion, and can show equal strength, power, and agility during functional testing of the affected extremity.</p><p>Joint-specific goals of PT include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Knee</strong> – Stretching of the quadriceps and hamstring muscles, improved quadriceps and core abdominal muscle strength, including the multifidus, transverse abdominis, and gluteus medius</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Elbow</strong> – Scapulothoracic stabilization and strengthening (eg, conditioning of the rhomboid; upper, mid, and lower trapezius; levator scapulae, and serratus anterior muscles) and rotator cuff muscle strengthening to help decrease the valgus load at the elbow during repetitive overhead and throwing motions</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ankle</strong> – Strengthening of the ankle stabilizers (eg, conditioning of the tibialis anterior, peroneus longus, peroneus brevis, and tibialis posterior muscles, and the gastrocnemius and soleus complex) and improved proprioception (eg, balancing exercises and strengthening of core and gluteus medius muscles)</p><p></p><p class="headingAnchor" id="H3267112"><span class="h2">Nonsteroidal antiinflammatory drugs</span><span class="headingEndMark"> — </span>Rest and immobilization are the primary treatments for pain caused by OCD. Nonsteroidal antiinflammatory drugs (NSAIDs; eg, <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">ibuprofen</a>) may be used for short-term pain relief during the first three days of treatment.</p><p class="headingAnchor" id="H315785"><span class="h1">SURGICAL TREATMENT</span><span class="headingEndMark"> — </span>Surgical management is warranted for children with juvenile OCD that have a loose body (Stage IV) or have not responded to four to six months of nonoperative therapy. A significant proportion of OCD lesions in children and adolescents require surgical management. As an example, in a retrospective observational study of over 300 children 2 to 19 years of age with OCD, approximately 35 percent of patients received surgical treatment including approximately one third of patients with knee or ankle lesions and just over half of patients with elbow lesions [<a href="#rid13">13</a>]. Older patients (12 to 19 years of age) were much more likely to progress to surgical intervention than younger patients (6 to 11 years of age) based upon adjusted analysis. Patient sex was not associated with progression to surgical management.</p><p>Nonoperative treatment is a reasonable first option for patients with adult OCD who have small, stable (Stage I or II) lesions  (<a class="graphic graphic_table graphicRef85755" href="/z/d/graphic/85755.html" rel="external">table 1</a>) although the likelihood of healing is approximately 50 percent or less [<a href="#rid2">2,10</a>]. Thus, most patients with adult OCD warrant surgical repair. (See <a class="local">'Nonoperative treatment'</a> above.)</p><p>The operative management of OCD is based upon case series and expert opinion [<a href="#rid3">3</a>]. Evidence that compares outcomes among the different types of operative treatment is lacking. There are multiple surgical techniques for OCD that include autologous chondrocyte implantation, autograft osteochondral implantation/transfer (plugs), allograft osteochondral implantation, arthroscopic drilling, metallic screw fixation, and microfracture [<a href="#rid10">10-12,14-19</a>]. The choice of technique depends upon the patient’s skeletal maturity, the stage of the OCD fragment  (<a class="graphic graphic_table graphicRef85755" href="/z/d/graphic/85755.html" rel="external">table 1</a>), and the size of the lesion [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H6045191"><span class="h1">FOLLOW-UP</span><span class="headingEndMark"> — </span>Patients receiving nonoperative treatment typically undergo clinical evaluation every two weeks while being immobilized. We obtain plain radiographs at 6 weeks and 12 weeks to assess for bony healing. Patients with radiographic improvement at 12 weeks should undergo clinical evaluation and follow-up radiographs every three months until full healing is documented. Patients who do not show radiographic evidence of healing at 12 weeks warrant referral to an orthopedic surgeon [<a href="#rid1">1,3</a>].</p><p class="headingAnchor" id="H6045199"><span class="h1">RETURN TO ACTIVITY</span><span class="headingEndMark"> — </span>Before returning to competition, the patient should be pain free with return of full active range of motion, strength, and endurance. The patient should gradually return to running, sprinting, cutting, and sport-specific exercises. A gradual return to sport with increasing intensity is allowed as long as there are no symptoms. The timing for return to play varies by lesion location, lesion stage  (<a class="graphic graphic_table graphicRef85755" href="/z/d/graphic/85755.html" rel="external">table 1</a>), rate of improvement, and type of treatment [<a href="#rid10">10</a>]. Patients who rapidly respond to nonoperative treatment may return to activity as early as 12 weeks. However, return to play may be delayed as long as six months or longer in other patients in whom healing is delayed [<a href="#rid7">7</a>].</p><p>In our experience, patients with complete healing after surgical treatment typically can return to play within six months to one year of diagnosis.</p><p class="headingAnchor" id="H6044728"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>Patients with complete healing of OCD should have full recovery of joint function. Complete healing is most commonly seen in skeletally immature patients with Stage I or II lesions of the knee or elbow  (<a class="graphic graphic_table graphicRef85755" href="/z/d/graphic/85755.html" rel="external">table 1</a>). These lesions have rates of healing that approach 95 percent [<a href="#rid2">2,3,10,11,20,21</a>].</p><p>In contrast, skeletally mature patients and patients with Stage III or IV lesions are less likely to have complete healing and approximately 50 percent of these patients are at risk for chronic pain, mechanical symptoms, and arthritis [<a href="#rid1">1,3,20,22,23</a>].</p><p class="headingAnchor" id="H3289531094"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/113722.html" rel="external">"Society guideline links: Knee pain"</a>.)</p><p class="headingAnchor" id="H6045183"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>The need for specialty referral primarily depends upon the likelihood that the OCD lesion will not heal with nonoperative therapy. Healing is largely determined by skeletal maturity, characteristics of the OCD lesion (ie, size or stability), and the joint affected. Specific indications for specialty referral are presented. (See <a class="local">'Indications for subspecialty referral or consultation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We suggest that children with Stage I, II, or III juvenile OCD of the knee, elbow, or ankle initially undergo nonoperative therapy consisting of rest, immobilization, and physical therapy rather than surgical repair  (<a class="graphic graphic_table graphicRef85755" href="/z/d/graphic/85755.html" rel="external">table 1</a>) (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Nonoperative treatment is also a reasonable first option for patients with adult OCD who have small, stable (Stage I or II) lesions. (See <a class="local">'Nonoperative treatment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children with juvenile OCD that have a loose body (Stage IV) or have not responded to four to six months of nonoperative therapy and most patients with adult OCD warrant surgical repair. (See <a class="local">'Surgical treatment'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Edmonds EW, Polousky J. A review of knowledge in osteochondritis dissecans: 123 years of minimal evolution from König to the ROCK study group. Clin Orthop Relat Res 2013; 471:1118.</a></li><li><a class="nounderline abstract_t">Wall EJ, Vourazeris J, Myer GD, et al. The healing potential of stable juvenile osteochondritis dissecans knee lesions. J Bone Joint Surg Am 2008; 90:2655.</a></li><li><a class="nounderline abstract_t">Chambers HG, Shea KG, Carey JL. AAOS Clinical Practice Guideline: diagnosis and treatment of osteochondritis dissecans. J Am Acad Orthop Surg 2011; 19:307.</a></li><li><a class="nounderline abstract_t">Takahara M, Mura N, Sasaki J, et al. Classification, treatment, and outcome of osteochondritis dissecans of the humeral capitellum. J Bone Joint Surg Am 2007; 89:1205.</a></li><li><a class="nounderline abstract_t">Krause M, Hapfelmeier A, Möller M, et al. Healing predictors of stable juvenile osteochondritis dissecans knee lesions after 6 and 12 months of nonoperative treatment. Am J Sports Med 2013; 41:2384.</a></li><li><a class="nounderline abstract_t">Sakata J, Miyazaki T, Akeda M, Yamazaki T. Predictors of Failure of Return to Play in Youth Baseball Players After Capitellar Osteochondritis Dissecans: Focus on Elbow Valgus Laxity and Radiocapitellar Congruity. Am J Sports Med 2021; 49:353.</a></li><li><a class="nounderline abstract_t">Perumal V, Wall E, Babekir N. Juvenile osteochondritis dissecans of the talus. J Pediatr Orthop 2007; 27:821.</a></li><li><a class="nounderline abstract_t">Tol JL, Struijs PA, Bossuyt PM, et al. Treatment strategies in osteochondral defects of the talar dome: a systematic review. Foot Ankle Int 2000; 21:119.</a></li><li><a class="nounderline abstract_t">Kim HW, Park KB, Kim CW, et al. Healing Predictors of Conservative Treatment for Juvenile Osteochondritis Dissecans of the Talus. Clin J Sport Med 2022; 32:e635.</a></li><li class="breakAll">DeLee JC, Drez Jr D, Miller MD. DeLee &amp; Drez's Orthopaedic Sports Medicine Principles and Practice, 2nd ed, Elsevier Science, Philadelphia 2003.</li><li><a class="nounderline abstract_t">Polousky JD. Juvenile osteochondritis dissecans. Sports Med Arthrosc 2011; 19:56.</a></li><li><a class="nounderline abstract_t">Kocher MS, Tucker R, Ganley TJ, Flynn JM. Management of osteochondritis dissecans of the knee: current concepts review. Am J Sports Med 2006; 34:1181.</a></li><li><a class="nounderline abstract_t">Weiss JM, Nikizad H, Shea KG, et al. The Incidence of Surgery in Osteochondritis Dissecans in Children and Adolescents. Orthop J Sports Med 2016; 4:2325967116635515.</a></li><li><a class="nounderline abstract_t">De Smet AA, Ilahi OA, Graf BK. Reassessment of the MR criteria for stability of osteochondritis dissecans in the knee and ankle. Skeletal Radiol 1996; 25:159.</a></li><li><a class="nounderline abstract_t">Ruch DS, Cory JW, Poehling GG. The arthroscopic management of osteochondritis dissecans of the adolescent elbow. Arthroscopy 1998; 14:797.</a></li><li><a class="nounderline abstract_t">Gudas R, Simonaityte R, Cekanauskas E, Tamosiūnas R. A prospective, randomized clinical study of osteochondral autologous transplantation versus microfracture for the treatment of osteochondritis dissecans in the knee joint in children. J Pediatr Orthop 2009; 29:741.</a></li><li><a class="nounderline abstract_t">Edmonds EW, Albright J, Bastrom T, Chambers HG. Outcomes of extra-articular, intra-epiphyseal drilling for osteochondritis dissecans of the knee. J Pediatr Orthop 2010; 30:870.</a></li><li><a class="nounderline abstract_t">Tabaddor RR, Banffy MB, Andersen JS, et al. Fixation of juvenile osteochondritis dissecans lesions of the knee using poly 96L/4D-lactide copolymer bioabsorbable implants. J Pediatr Orthop 2010; 30:14.</a></li><li><a class="nounderline abstract_t">Steinhagen J, Bruns J, Deuretzbacher G, et al. Treatment of osteochondritis dissecans of the femoral condyle with autologous bone grafts and matrix-supported autologous chondrocytes. Int Orthop 2010; 34:819.</a></li><li><a class="nounderline abstract_t">Matsuura T, Kashiwaguchi S, Iwase T, et al. Conservative treatment for osteochondrosis of the humeral capitellum. Am J Sports Med 2008; 36:868.</a></li><li><a class="nounderline abstract_t">Mihara K, Suzuki K, Makiuchi D, et al. Surgical treatment for osteochondritis dissecans of the humeral capitellum. J Shoulder Elbow Surg 2010; 19:31.</a></li><li><a class="nounderline abstract_t">Takahara M, Ogino T, Fukushima S, et al. Nonoperative treatment of osteochondritis dissecans of the humeral capitellum. Am J Sports Med 1999; 27:728.</a></li><li><a class="nounderline abstract_t">Takahara M, Ogino T, Sasaki I, et al. Long term outcome of osteochondritis dissecans of the humeral capitellum. Clin Orthop Relat Res 1999; :108.</a></li></ol></div><div id="topicVersionRevision">Topic 85774 Version 16.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22362466" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A review of knowledge in osteochondritis dissecans: 123 years of minimal evolution from König to the ROCK study group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19047711" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The healing potential of stable juvenile osteochondritis dissecans knee lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21536630" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : AAOS Clinical Practice Guideline: diagnosis and treatment of osteochondritis dissecans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17545422" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Classification, treatment, and outcome of osteochondritis dissecans of the humeral capitellum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23876519" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Healing predictors of stable juvenile osteochondritis dissecans knee lesions after 6 and 12 months of nonoperative treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33321050" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Predictors of Failure of Return to Play in Youth Baseball Players After Capitellar Osteochondritis Dissecans: Focus on Elbow Valgus Laxity and Radiocapitellar Congruity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17878792" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Juvenile osteochondritis dissecans of the talus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10694023" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Treatment strategies in osteochondral defects of the talar dome: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36315829" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Healing Predictors of Conservative Treatment for Juvenile Osteochondritis Dissecans of the Talus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36315829" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Healing Predictors of Conservative Treatment for Juvenile Osteochondritis Dissecans of the Talus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21293239" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Juvenile osteochondritis dissecans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16794036" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Management of osteochondritis dissecans of the knee: current concepts review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27047984" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The Incidence of Surgery in Osteochondritis Dissecans in Children and Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8848747" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Reassessment of the MR criteria for stability of osteochondritis dissecans in the knee and ankle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9848588" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The arthroscopic management of osteochondritis dissecans of the adolescent elbow.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20104156" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : A prospective, randomized clinical study of osteochondral autologous transplantation versus microfracture for the treatment of osteochondritis dissecans in the knee joint in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21102215" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Outcomes of extra-articular, intra-epiphyseal drilling for osteochondritis dissecans of the knee.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20032736" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Fixation of juvenile osteochondritis dissecans lesions of the knee using poly 96L/4D-lactide copolymer bioabsorbable implants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19626325" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Treatment of osteochondritis dissecans of the femoral condyle with autologous bone grafts and matrix-supported autologous chondrocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18219050" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Conservative treatment for osteochondrosis of the humeral capitellum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19556146" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Surgical treatment for osteochondritis dissecans of the humeral capitellum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10569357" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Nonoperative treatment of osteochondritis dissecans of the humeral capitellum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10379311" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Long term outcome of osteochondritis dissecans of the humeral capitellum.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
